Treatment methods after resistance to selumetinib

Selumetinib is a drug commonly used to treat neurofibromatosis type 1 (NF1) cancer. Although selumetinib is effective at inhibiting tumor growth in many patients, sometimes cancer cells can become resistant to it. NF1 is a lifelong disease, and patients with NF1 are reported to have a reduced life expectancy of 10-15 years, although estimates of life expectancy with currently available medical management are unclear.

When a patient becomes resistant to selumetinib, the doctor may re-evaluate the patient's condition and adjust the treatment plan according to the specific situation. This may include switching to other chemotherapy drugs or combining them with other targeted therapies in the hope of achieving better results. Some studies suggest that increasing the dose of selumetinib may help overcome resistance in some patients. However, this requires careful evaluation of the patient's overall condition and close collaboration with the physician to determine whether it is appropriate to attempt an increase in dosage. If there are new investigational drugs or treatment regimens in clinical trials that are associated with resistance to selumetinib, doctors may recommend that patients participate in those trials. This helps explore new treatment options and improve treatment outcomes. However, everyone’s physique is different and their resistance to drugs is also different. If you feel unwell, please inform your doctor in time.

SelumetinibThe original drug has been launched in China, but it has not yet entered the scope of medical insurance. SpecificationThe price of 10mg*60 tablets per box may be more than 20,000 yuan, which is relatively expensive. SelumetinibOriginal drug marketed overseas, the price of 10mg*60 pills per box may be more than 50,000 yuan, and the price of 25mg*60 pills per box may be 1 More than RMB 00,000 (the price may fluctuate due to the exchange rate). The ingredients of the original version of selumetinib sold at home and abroad are basically the same. There is currently no generic version of selumetinib on the market. For more drug information and specific prices, please consult Yaode Medical Consultants.